Pedulla Denise E 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Pedulla Denise E
General Counsel
Transactions
- Award
Common Stock
2020-03-02+2,912→ 43,988 total - Award
Common Stock
2020-03-02$28.33/sh+18,757$531,386→ 18,757 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (18,757 underlying)
Holdings
- 15,000
Common Stock
Exercise: $7.85From: 2016-12-08Exp: 2020-12-08→ Common Stock (15,000 underlying) - 48,334
Common Stock
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,334 underlying) - 17,496
Common Stock
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying) - 25,000
Common Stock
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.